Acceptability of school requirements for human papillomavirus vaccine

Human Vaccines

Volumn 7, Issue 9, 2011, Pages 952-957

  Smith, Jennifer S ^a,b   Brewer, Noel T ^a,b   Chang, Yuli ^a   Liddon, Nicole ^c   Guerry, Sarah ^d   Pettigrew, Erica ^e   Markowitz, Lauri E ^c   Gottlieb, Sami L ^c  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Los Angeles County Department of Public Health   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical cancer; Human papillomavirus; Implementation; Mandates; Public policy; Requirements; Vaccine

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONFIDENCE INTERVAL; DRUG EFFICACY; DRUG SAFETY; EDUCATION; FEMALE; HUMAN; LAW; LOGISTIC REGRESSION ANALYSIS; MALE; PARENT; PARENTAL ATTITUDE; PREDICTION; RISK ASSESSMENT; SCHOOL; SCHOOL REQUIREMENT; UNITED STATES; UTERINE CERVIX CANCER; VACCINATION;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 80053550234     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.7.9.15995     Document Type: Article

References (39)

1. Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356:1928-43. PMID:17494926 http://dx.doi.org//10.1056/NEJMoa061760
2. Harper DM, Franco EL, Wheeler CM Moscicki AB, Romanowski D, Roteli-Martins CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006; 367:1247-55. PMID:16631880 http://dx.doi.org/10.1016/S0140-6736(06)68439-0
3. Centers for Disease Control and Prevention. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). 3-23-2007.
4. Hinman AR, Orenstein WA, Williamson DE, Darrington D. Childhood immunization: laws that work. J Law Med Ethics 2002; 30(Suppl):122-7. PMID:12508514 (Pubitemid 39277887)
5. Averhoff F, Linton L, Peddecord KM. A middle school immunization law rapidly and substantially increases immunization coverage among adolescents. Am J Public Health 2004; 94:978-84. PMID:15249302 http://dx.doi.org/10.2105/AJPH. 94.6.978
6. Task Force on Community Preventive Services. Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and adults. Am J Prev Med2000;18(1S):92-6
7. Opel DJ, Diekema DS, Marcuse EK. A critique of criteria for evaluating vaccines for inclusion in mandatory school immunization programs. Pediatrics 2008; 122:e504-10. PMID:18676536 http://dx.doi.org/10.1542/peds.2007-3218
8. Charo RA. Politics, parents, and prophylaxis-mandating HPV vaccination in the United States. N Engl J Med 2007; 356:1905-8. PMID:17494922 http://dx.doi.org/10.1056/NEJMp078054
9. Colgrove J, Abiola S, Mello MM. HPV vaccination mandates-lawmaking amid political and scientific controversy. N Engl J Med 2010; 363:785-91. PMID:20818883 http://dx.doi.org/10.1056/NEJMsr1003547
10. National Conference of State Legislatures. HPV Vaccine: State Legislation and Statutes. http://www.ncsl.org/programs/health/HPVvaccine.htm. 2008.
11. Wynia MK. Public health, public trust and lobbying. Am J Bioeth 2007; 7:4-7. PMID:17558977 http://dx.doi.org/10.1080/15265160701429599
12. Centers for Disease Control. Reports of Health Concerns Following HPV Vaccination. 2010. http://www.cdc.gov/vaccinesafety/Vaccines/HPV/gardasil.html
13. Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 2009; 302:750-7. PMID:19690307 http://dx.doi.org/10. 1001/jama.2009.1201
14. CDC's Reports of Health Concerns Following HPV Vaccination http://www.cdc.gov/vaccinesafety/vaccines/hpv/gardasil.html. 2011.
15. Centers for Disease Control. Tetanus, Diphtheria, (Pertussis) Mandates for Secondary Schools. March 2010. www.immunize.org/laws/tdap.pdf. 2010.
16. Orenstein WA, Hinman AR. The immunization system in the United States - the role of school immunization laws. Vaccine 1999; 17(Suppl 3):S19-24. PMID:10559531 http://dx.doi.org/10.1016/S0264-410X(99)00290-X
17. Schwartz JL, Caplan AL, Faden RR, Sugarman J. Lessons from the failure of human papillomavirus vaccine state requirements. Clin Pharmacol Ther 2007; 82:760-3. PMID:17971822 http://dx.doi.org/10.1038/sj.clpt.6100397
18. Immunization Action Coalition. State mandates on immunization and vaccine preventable diseases. http://www.immunize.org/. 6-11-2007.
19. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007; 45:107-14. PMID:17628649 http://dx.doi.org/10.1016/j.ypmed.2007.05.013
20. Brewer NT, Cuite CL, Herrington JE, Weinstein ND. Risk compensation and vaccination:can getting vaccinated cause people to engage in risky behaviors? Ann Behav Med 2007; 34:95-9. PMID:17688401 http://dx.doi.org/10.1007/BF02879925
21. Blumberg SJ, Luke JV, Cynamon ML. Telephone coverage and health survey estimates: evaluating the need for concern about wireless substitution. Am J Public Health 2006; 96:926-31. PMID:16571707 http://dx.doi.org/10.2105/AJPH. 2004.057885
22. CDC's Report on Childcare and School Immunizations Requirements.2008 May 20, 2009.
23. Association of Immunization Managers. Position Statement, School and Child Care Immunization Requirements. http://www.immunizationmanagers.2010.
24. Haber G, Malow RM, Zimet GD. The HPV vaccine mandate controversy. J Pediatr Adolesc Gynecol 2007; 20:325-31. PMID:18082853 http://dx.doi.org/10. 1016/j.jpag.2007.03.101
25. Laugesen MJ, Paul RR, Luft HS, Aubry W, Ganiats TG. A comparative analysis of mandated benefit laws, 1949-2002. Health Serv Res 2006; 41:1081-103. PMID:16704673 http://dx.doi.org/10.1111/j.1475-6773.2006.00521.x
26. Omer SB, Salmon DA, Orenstein WA, deHart M, Halsey NA. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med 2009; 360:1981-8. PMID:19420367 http://dx.doi.org/10.1056/NEJMsa0806477
27. Omer SB, Pan WK, Halsey NA Stokley S, Moulton LH, Navar AM, et al. Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence. JAMA 2006; 296:1757-63. PMID:17032989 http://dx.doi.org/10.1001/jama.296.14.1757
28. National Vaccine Advisory Committee (NVAC). Mandates for Adolescent Immunization: Recommendation from National Vaccine Advisory Committee (NVAC). AJPM. 35[2]. 2008.
29. Horlick G, Shaw FE, Gorji M, Fishbein DB. Delivering new vaccines to adolescents: the role of school-entry laws. Pediatrics 2008; 121(Suppl 1):S79-84. PMID:18174324 http://dx.doi.org/10.1542/peds.2007-1115I
30. Shefer A, Markowitz L, Deeks S, Tam T, Irwin K, Garland SM, et al. Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia. Vaccine 2008; 26(Suppl 10):K68-75. PMID:18847559 http://dx.doi.org/10.1016/j.vaccine.2008.05.065
31. Annual HPV vaccine coverage in England in 2009/2010 http://www.dh.gov.uk/ prod-consum-dh/groups/dh-digitalassets/documents/digitalasset/dh-123826.pdf
32. Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, Mola G, et al. Human papillomavirus and cervical cancer in Australasia and Oceania: riskfactors, epidemiology and prevention. Vaccine 2008; 26(Suppl 12):M80-8. PMID:18945417 http://dx.doi.org/10.1016/j.vaccine.2008.05.041
33. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2009. [Electronic version]. MMWR Morb Mortal Wkly Rep 2010; 59:1018-23. PMID:20724968
34. Hayes, K.A., Entzel, P., Berger, W., Caskey, R.L., Shlay, J.A., Stubbs, B., Smith, J.S.& Brewer, N.T., (2011). Early lessons learned from extramural vaccination programs that offer HPV vaccine in US schools.
35. Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev 2009; 18:363-72. PMID:19190161 http://dx.doi.org/10.1158/1055-9965.EPI-08-0418
36. U.S.Census Bureau. Census glossary. http://factfinder.census.gov/home/en/ epss/glossary-a.html. 2008.
37. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007; 45:107-14. PMID:17628649 http://dx.doi.org/10.1016/j.ypmed.2007.05.013
38. Brewer NT, Gottlieb S, Reiter PL, McRee, AL, Liddon N, Markowitz L, Smith JS. Longitudinal Predictors of HPV Vaccine Uptake", Sex Transm Dis. 2010 Sep 10.
39. US Census Bureau. State Population Estimates. http://www.census.gov/ popest/states/asrh/SC-EST2007-03.html. 2009.